Spark Therapeutics Profile

44.75
USD 2.97  6.22%
44.75Last Month High 74.11 
44.44Trading Day  High 47.34 

Exercise or conversion by Katherine High of 5000 shares of Spark Therapeutics subject to Rule 16b-3

Spark Therapeutics Inc insider trading alert for exercise of stock option (right to buy) by Katherine High, President and Head of Research and Development, on November 29, 2017. This event was filed by Spark Therapeutics Inc with SEC on 2017-11-29. Statement of changes in beneficial ownership - SEC Form 4. Katherine High is currently serves as president chief scientific officer, director of Spark Therapeutics Inc [view details]   

Spark Therapeutics Summary

Spark Therapeutics Inc (ONCE) is traded on NASDAQ in USA. It is located in PENNSYLVANIA, U.S.A and employs 113 people. Spark Therapeutics is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Mid-Cap' category with current market capitalization of 2.72 B. Spark Therapeutics Inc has 37.01 M outstanding shares of which 2.89 M shares are now shorted by private and institutional investors with about 5.68 trading days to cover. N/A currently holds about 478.7 M in cash with (156.39 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 12.94.
Check Spark Therapeutics Probability Of Bankruptcy

Ownership Allocation (%)

Top Holders

Selected Spark Therapeutics Inc Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

Spark Therapeutics Against Markets

Current Ratings  

Spark Therapeutics 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
0 
Chance of
< 51% 
Spark Therapeutics, Inc. focuses on the development of gene therapy solutions for patients suffering from debilitating genetic diseases. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
NameSpark Therapeutics Inc
Analyst Consensus
Piotroski F Score
Macroaxis Advice
InstrumentUSA Stock Stocks Directory
RegionNorth America
LocationPENNSYLVANIA, U.S.A
Business AddressSpark Therapeutics, Inc.Philadelphia, PA
ExchangeNASDAQ
CIK Number01609351.0
CUSIP84652J103
IndustryPharmaceutical Products
BenchmarkDOW
Websitewww.sparktx.com
Contact Number888 772 7560
CurrencyUSD - US Dollar

Recommendations

Spark Therapeutics Analyst Recommendations
Target PriceAdvice# of Analysts
66.83Buy12Odds
Spark Therapeutics Inc current and past analyst recommendations published by number of research institutions as well as average analyst consensus
Spark Therapeutics Analyst Advice  

Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  

Earnings

Spark Therapeutics Earnings Estimates
EPSEstimate Date
Quarterly Estimate-1.35May 3, 2017
Spark Therapeutics Inc normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate